Member Info for passiton

Bit carried away , both SNG and TILS are treatments not cure's, their effect is on the body not the disease
its your own immune system that gets the virus given the chance
The drugs prevent lungs closing up (alleviates need for ventilator) so lungs can maintain the lungs and
breath oxygen to supply the vital organs to prevent organ failure and deaths being suffered currently.
So massive step forward, inhaler's allow quicker direct access to the lungs, the Cuban and others used
in China all injection/iv based which take time to build up in the system and get to work on the lungs
The saved will save lives NO BIGGER TARGET than that.

US pre market not worth looking at it tends to just float following us, been watching it the past month
would not read anything into it until near open, just like London at 07:50 'ish it will reset and give
an indication where they are planning to trade it, more churn $3.10-$3.40 like Thursday/Monday
or finally release the handbrake. GLA

Best estimate I have seen was a professor out of one of the Oxford Uni Labs a few days ago said she
was 80% certain at this stage the vaccine they are working on would WORK and target of September
Hope she's right
Being a virus there is no cure only treatments, so the inhaler direct to lungs treatment s so the body
can breath oxygen to the vital organs so immune system can fight back is as good as it's going to be
for some time yet
Only seen 2 candidates in the news for il-6 control inhaler/nebuliser sng and tils

volume only 2m though, Nasdaq did the equivalent of almost 40m last Thursday when we did 4.5m
and 5.5m on Nasdaq yesterday, test of the rise will come when they open and if overhang cleared
we will move freely at last.

Raised $10m last month on Nasdaq and installed a new additional up to $20m funding last week
so if the new funding , currently being churned it wont take long ,at same raise as last month $3
its only 6.66m US shares they churned 8M on Friday (40m =AIM)

The move was to kill AIM and be JUST USA Nasdaq as more supportive of Pharms, not the tail wagging
the dog, they are now the dog as raises/placing done over there not here in London $10 and $20m
worth this past month. Also when news ,they are trading 10 times the share volume seen on AIM
THAT'S SEEM'S IN CHARGE...…..

Nasdaq is the primary listing as per plan to delist from AIM Q2 (RNA'd) due to better support for pharm
stocks in the USA than London.
(plan may be shelved now as pharm's the top stocks)

Friday AIM 4.5million shares traded , Nasdaq almost 8 million which at 5v1 = 40Million AIM shares

Link below if you want to follow todays Nasdaq opens UK 2:30PM
Clear the fund raising/placing overhang on TLSA Nasdaq and TLSA/TILS should bounce big time. GLA

Nasdaq when open Friday was rangebound $3.10-$3.40 back and forth all day.
(placing was at $3 ex rate at time 0.81 = 48.6p equiv)

https://www.nasdaq.com/market-activity/stocks/tlsa

Ignore current random fluctuations, just like London it will reset. Currently $3.08 up from $2.65
when I loaded it up

Patent is legal protection, once in depth details registered and approved, NOBODY else can manufacture
an identical product, they would have to be permitted and licenced by TILS to do so for a small fee or
share of the profits of course.

https://www.marketbeat.com/stocks/NASDAQ/TLSA/

Basically the Cuban drug used in china and the TILS and SNG have the same function but the Cuban is
injected so takes time to get working on the affected area the lungs, the Inhaler goes straight to the lungs
so precious time saved in getting to work, the difference should save many more lives

Sam hopefully they are just cruising in a holding pattern until all the stateside orders can be
executed and they take the lead as it is now effectively the primary listing can follow it over
there on link

https://www.nasdaq.com/market-activity/stocks/tlsa

Would have though at worst, with a big boy like Barclay's you may have to upgrade type of account for wider
access, if the one its currently in does not give you direct access to foreign markets, or you may just be stuck
with shares in same account but have to trade by phone. You will get them one way or another. As said
earlier might not now happen as the world has changed. Money will be no object to Drug and Vaccine
developments in future, the Gov's etc will not want this to happen again,without upgrading preparations
for in the event of

Sorry Sam, just got back and saw your post, looks like someone already gave a pretty in depth reply
and it is usually the case of share transfer, in this case you would get 1 US for every 5 aim you hold
Down side is, had this happen before and might want to check account broker if it does still get
announced, some accounts fine for such transfers, some not i.e. only permit holding uk stocks

Delist on AIM was the plan for Q2 after listing in the USA, they like the pharm stocks, now pharm stocks
back as flavour of the year, they may change their mind as would now get better support/finance than
had been available previously.

Good Friday one of Nasdaq listed holiday days

FDA announced the other day they have multiple FAST TRACK drugs in play, the normal rules are out of
the window, if it works in live trials that are currently being conducted, the Americans will have it in
ICU's in a flash.
Just hoping ours is included in that fast track program

Because it was getting no support or funding in London, Tils might change its mind now PHARMA stocks
are flavour of the year everywhere

just shadowing our movement like it did last month pre open which is 06:30 / 10:30 right now for the big
players to place orders pre market open 0700 / 11:00
NYSE opening hours 0630-2000 EST 1030-0100 uk

CORE opening 0930-1600 uk 1430-2100 for the rest and pi's

NYSE Opens for the big players at 0630 EST 10:30 UK pre market orders for 0700-2000 OPEN - 11am UK
core open for the lesser lights and PI's 0930-1600 1430-2100 UK

Hopefully, some of those bigger market players will be chomping at the bit for 11 o'clock GLA

Makes a lot of good/great calls, if your on twits, well worth following his posts, now doing for himself
and helping others, with what use to be his professional day job, as an investments analyst